Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli BL21(DE3) cells | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(E)-4-(2-(5,6-dimethylbenzo[d]thiazol-2-yl)vinyl)-N,N-diethylbenzenesulfonamide | 96% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(5-bromobenzo[d]thiazol-2-yl)vinyl)-N,N-diethylbenzenesulfonamide | 82% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(5-chlorobenzo[d]thiazol-2-yl)vinyl)-N,N-diethylbenzenesulfonamide | 89% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(6-bromobenzo[d]thiazol-2-yl)vinyl)-N,N-diethylbenzenesulfonamide | 21% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-2-chloro-N,N-diethylbenzenesulfonamide | 12% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-N,N-diethyl-2-fluorobenzenesulfonamide | 18% inhibition at 0.1 mM; 28% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-N,N-diethyl-2-methylbenzenesulfonamide | 30% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-N,N-diethylbenzenesulfonamide | competitive inhibition, complete inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-N,N-dimethylbenzenesulfonamide | 14% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-N-(4-methoxyphenyl)benzenesulfonamide | 28% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-N-(4-methylbenzyl)benzenesulfonamide | 33% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-N-benzylbenzenesulfonamide | 11% inhibition at 0.1 mM | Homo sapiens | |
(E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-N-phenylbenzenesulfonamide | 25% inhibition at 0.1 mM | Homo sapiens | |
(E)-N,N-diethyl-4-(2-(5-fluorobenzo[d]thiazol-2-yl)vinyl)benzenesulfonamide | 84% inhibition at 0.1 mM | Homo sapiens | |
(E)-N,N-diethyl-4-(2-(5-methoxybenzo[d]thiazol-2-yl)vinyl)benzenesulfonamide | 13% inhibition at 0.1 mM | Homo sapiens | |
(E)-N,N-diethyl-4-(2-(5-methylbenzo[d]thiazol-2-yl)vinyl)benzenesulfonamide | 14% inhibition at 0.1 mM | Homo sapiens | |
2-[2-(4-heptylphenyl)ethyl]-6-hydroxybenzoic acid | complete inhibition at 0.05 mM | Homo sapiens | |
MG149 | complete inhibition at 0.05 mM | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
acetyl-CoA + [histone H4]-L-lysine16 | Homo sapiens | - |
CoA + [histone H4]-N6-acetyl-L-lysine16 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9H7Z6 | - |
- |
Purification (Comment) | Organism |
---|---|
HisTrap column chromatography and Superdex 75 gel filtration | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HCT-116 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
acetyl-CoA + [histone H4]-L-lysine16 | - |
Homo sapiens | CoA + [histone H4]-N6-acetyl-L-lysine16 | - |
? |
Synonyms | Comment | Organism |
---|---|---|
HAT | - |
Homo sapiens |
KAT8 | - |
Homo sapiens |
Mof | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.006 | - |
at pH 7.5 and 25°C | Homo sapiens | (E)-4-(2-(benzo[d]thiazol-2-yl)vinyl)-N,N-diethylbenzenesulfonamide | |
0.0077 | - |
at pH 7.5 and 25°C | Homo sapiens | (E)-4-(2-(5,6-dimethylbenzo[d]thiazol-2-yl)vinyl)-N,N-diethylbenzenesulfonamide | |
0.015 | - |
at pH 7.5 and 25°C | Homo sapiens | 2-[2-(4-heptylphenyl)ethyl]-6-hydroxybenzoic acid | |
0.03 | - |
at pH 7.5 and 25°C | Homo sapiens | (E)-4-(2-(5-bromobenzo[d]thiazol-2-yl)vinyl)-N,N-diethylbenzenesulfonamide | |
0.03 | - |
at pH 7.5 and 25°C | Homo sapiens | (E)-4-(2-(5-chlorobenzo[d]thiazol-2-yl)vinyl)-N,N-diethylbenzenesulfonamide | |
0.04 | - |
at pH 7.5 and 25°C | Homo sapiens | (E)-N,N-diethyl-4-(2-(5-fluorobenzo[d]thiazol-2-yl)vinyl)benzenesulfonamide |